Emdeon Corporation’s Registration Statement Relating To 3 - 1/8% Convertible Notes Filed And Declared Effective

ELMWOOD PARK, N.J., Dec. 20 /PRNewswire-FirstCall/ -- Emdeon Corporation today filed a Registration Statement on Form S-3 relating to the offer and resale by certain of its security holders of $300,000,000 aggregate principal amount of 3 - 1/8% Convertible Notes due 2025 previously issued by Emdeon and shares of Emdeon common stock issuable upon conversion of the Notes. The Registration Statement was automatically declared effective by the Securities and Exchange Commission upon filing.

Subject to, and in accordance with, the requirements of the Securities Act of 1933, as amended, and the rules and regulations thereunder, the selling security holders named in the Registration Statement are permitted to resell the Notes and the shares of Emdeon common stock issuable upon conversion of the Notes covered by the Registration Statement from time to time, as described in the “Plan of Distribution” section in the Prospectus that is a part of the Registration Statement. Emdeon will not receive any of the proceeds from the resale of the securities.

You may obtain copies of the Prospectus relating to the Notes from: Risa Fisher Vice-President - Investor Relations Emdeon Corporation 669 River Drive, Center 2 Elmwood Park, New Jersey 07407-1361 Tel: (201) 414-2002

This notice shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state.

About Emdeon

Emdeon is a leading provider of business, technology and information solutions that transform both the financial and clinical aspects of healthcare delivery. At the core of Emdeon’s vision is the commitment to connect providers, payers, employers, physicians and consumers in order to simplify business processes, to provide actionable knowledge at the right time and place and to improve healthcare quality.

Emdeon Business Services provides revenue cycle management and clinical communication solutions that enable payers, providers and patients to improve healthcare business processes. Emdeon Practice Services provides physician practice management and electronic health record software and services that increase practice efficiency and enhance patient care. WebMD Health provides health information services for consumers, physicians, healthcare professionals, employers and health plans through its public and private online portals and health-focused publications. Porex is a developer, manufacturer and distributor of proprietary porous plastic products and components used in healthcare, industrial and consumer applications.

All statements contained in this press release, other than statements of historical fact, are forward-looking statements. These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: market acceptance of our products and services; operational difficulties relating to combining acquired companies and businesses; our ability to form and maintain mutually beneficial relationships with customers and strategic partners; changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet, information technology and plastics industries, including matters relating to the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and our ability to attract and retain qualified personnel. Further information about these matters can be found in our Securities and Exchange Commission filings. We expressly disclaim any intent or obligation to update these forward-looking statements.

WebMD(R), WebMD Health(R), Emdeon(TM), Emdeon Business Services(TM), Emdeon Practice Services(TM) and POREX(R) are trademarks of Emdeon Corporation or its subsidiaries.

Emdeon Corporation

CONTACT: Investors - Risa Fisher, +1-201-414-2002, rfisher@emdeon.com,Jennifer Meyer Newman, +1-212-624-3912, jnewman@emdeon.com, both of Emdeon

MORE ON THIS TOPIC